GlassScriptPhysician profile
Thomas W Britt
NPI 1497860654
$694.78
in general payments reported to CMS, 2019-2025
18 companies · $79.97 in 2025
The $79.97 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $114 · 2021: $157 · 2022: $128 · 2023: $35.54 · 2024: $16.95 · 2025: $79.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $132.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $142.57 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $102.19 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $54.25 | 2019-2020 | |
| Lilly USA, LLC | $43.75 | 2019-2025 | Zepbound, Mounjaro |
| Abbvie INC. | $41.28 | 2022 | |
| Protega Pharmaceutials INC | $39.88 | 2025 | Roxybond |
| Allergan, INC. | $37.86 | 2020 | |
| Zyla Life Sciences, INC. | $34.62 | 2019 | |
| Novo Nordisk INC | $34.30 | 2019-2020 | |
| Amgen INC. | $25.04 | 2021 | |
| Exact Sciences Corporation | $24.84 | 2025 | Cologuard Collection Kit |
| Halozyme INC | $20.88 | 2023 | |
| Amarin Pharma, INC. | $19.77 | 2021 | |
| Astellas Pharma US INC | $15.90 | 2019 | |
| Eisai INC. | $15.07 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $14.91 | 2019 | |
| Pfizer INC. | $14.66 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $13.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Britt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.